Erlandsson, Lena
Ducat, Aurélien
Castille, Johann
Zia, Isac
Kalapotharakos, Grigorios
Hedström, Erik
Vilotte, Jean-Luc
Vaiman, Daniel http://orcid.org/0000-0002-1915-0717
Hansson, Stefan R.
Funding for this research was provided by:
INSERM and Cochin Institute
Knut och Alice Wallenbergs Stiftelse
Article History
Received: 10 October 2018
Accepted: 21 May 2019
First Online: 12 June 2019
Competing Interests
: Stefan R. Hansson holds patents related to diagnosis and treatment of preeclampsia and is co-founder of A1M Pharma AB and Preelumina Diagnostics (ExternalRef removed), as well as a shareholder. Lena Erlandsson and Erik Hedström are minor shareholders of A1M Pharma AB. All the remaining authors (A.D., J.C., I.Z., G.K., J.L.V. and D.V.) declare no competing interests.